NCT06543732 Vital@Work: Reintegration Program for Employees with Stress-related Complaints
| NCT ID | NCT06543732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Return to Work |
| Study Type | INTERVENTIONAL |
| Enrollment | 208 participants |
| Start Date | 2025-01-08 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 208 participants in total. It began in 2025-01-08 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study, Vital@Work reintegration program, is to support sick-listed workers with stress-related complaints in their return to work based on a personalized program. Therefore, the aim of this study is test whether participants supported by a tailored eHealth program, and if needed, additionally supported by a structured and stepwise Participatory Approach (PA) involving the sick-listed worker, their direct supervisor and a neutral party, show a faster and sustainable return to work as compared to participants in the control condition. This program is investigated in four different organizations, which differ in sector, size (small and large organizations), type of organization (private or public) and type of work.
Eligibility Criteria
Inclusion Criteria: * Sick-listed employees from participating organisations (Amsterdam UMC, GGZ inGeest, Rijksschoonmaakorganisatie \[RSO\], and Transavia) * Aged 18-68 * Between 2 and 12 weeks on sick leave * Suffering from stress-related complaints Exclusion Criteria: * Non-sick-listed employees * Suffering from severe psychiatric disorders (e.g., suicidality, mania, psychosis, schizophrenia) or other chronic conditions (e.g., terminal illness) that could significantly affect the employee's mental health and, hence, prevent the return-to work process * Being pregnant or less than three months after delivery * Sick-listed for more than 12 weeks * Inability to complete either the eHealth modules or questionnaires * Presence of a legal conflict with the employer * Not signing informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06543732 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 68 Years, studying Return to Work. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06543732 currently recruiting?
Yes, NCT06543732 is actively recruiting participants. Contact the research team at t.juurlink@amsterdamumc.nl for enrollment information.
Where is the NCT06543732 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Amsterdam, Netherlands, Amsterdam, Netherlands, The Hague, Netherlands.
Who is sponsoring the NCT06543732 clinical trial?
NCT06543732 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The trial plans to enroll 208 participants.